Molecular Testing System ID NOW™ COVID-19
The ID NOW™ COVID-19 assay is now available for use on the ID NOW platform under U.S. Food and Drug Administration Emergency Use Authorization (EUA). The ID NOW™ COVID-19 rapid test delivers high-quality molecular positive results in as little as 5 minutes, targeting the coronavirus (COVID-19) RdRp Gene.
Timely results enable healthcare professionals to make appropriate and more efficient treatment and infection control decisions. EUA supports flexible near patient testing environments.
STANDARD Q COVID-19 Ag
STANDARD Q COVID-19 Ag Test is a rapid chromatographic immunoassay for the qualitative detection of specific antigens to SARS-CoV-2 present in human nasopharynx.
Fast results within 30 mins
Easy to use
Specimen : Nasopharyngeal swab
All necessary reagents provided & no equipment needed
Covid-19 Diagnosis by IgG/IgM Rapid Test
For a rapid detection of anti-SARS-CoV-2 (2019-nCoV) IgG and IgM in 10-15 minutes during Covid-19
COVID-19 (Corona Virus Disease) is an infectious disease caused by the most recently discovered coronavirus, SARS-CoV-2 (2019-nCoV).
The rapid test for SARS-CoV-2 diagnosis provides qualitative detection of IgG and/or IgM from human serum, whole blood or plasma in approximately 10-15 minutes.
The rapid tests are based on the principle of lateral flow immunoassay chromatography and are available in cassette form. The test is based on the separation of the components of a mixture through a medium using capillary force and the specific and rapid binding of an antibody to its antigen.
IgM and IgG are immunoglobulins produced by the immune system to provide protection against SARS-CoV-2. Anti-SARS-CoV-2 IgM and IgG can therefore be detected in samples from affected patients.